NDRA: Endra Life Sciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Endra Life Sciences Inc (NDRA).
$3.36M Market Cap.
NDRA Market Cap. (MRY)
NDRA Shares Outstanding (MRY)
NDRA Assets (MRY)
Total Assets
$4.45M
Total Liabilities
$1.89M
Total Investments
$0
NDRA Income (MRY)
Revenue
$0
Net Income
-$11.51M
Operating Expense
$10.82M
NDRA Cash Flow (MRY)
CF Operations
-$7.40M
CF Investing
-$12.80K
CF Financing
$7.81M
NDRA Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $4,452,362 (-34.08%) | $6,754,146 (-27.17%) | $9,274,147 (-27.97%) | $12,874,644 (46.89%) |
Assets Current | $3,433,665 (13.22%) | $3,032,812 (-43.62%) | $5,379,397 (-55.52%) | $12,094,115 (47.35%) |
Assets Non-Current | $1,018,697 (-72.63%) | $3,721,334 (-4.45%) | $3,894,750 (398.99%) | $780,529 (40.07%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $2,560,366 (-54.76%) | $5,658,989 (-21.45%) | $7,204,504 (-33.19%) | $10,784,246 (50.42%) |
Property Plant & Equipment Net | $647,294 (38.94%) | $465,873 (-37.17%) | $741,471 (-4.27%) | $774,543 (40.51%) |
Cash & Equivalents | $3,229,480 (13.96%) | $2,833,907 (-42.04%) | $4,889,098 (-48.33%) | $9,461,534 (30.91%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $2,622,865 (-0.83%) | $2,644,717 (105.88%) | $1,284,578 (117.87%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $508,293 (-27.46%) | $700,754 (-53.99%) | $1,523,012 (7.91%) | $1,411,437 (55.07%) |
Accumulated Retained Earnings (Deficit) | -$103,438,099 (-12.52%) | -$91,930,152 (-12.29%) | -$81,869,902 (-19.19%) | -$68,690,810 (-19.80%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $1,383,703 (250.83%) | $394,403 (-27.85%) | $546,631 (-19.49%) | $678,961 (-0.95%) |
Debt Current | $96,937 (-52.09%) | $202,341 (11.97%) | $180,712 (36.56%) | $132,330 (73.03%) |
Debt Non-Current | $1,286,766 (569.97%) | $192,062 (-47.51%) | $365,919 (-33.06%) | $546,631 (-10.24%) |
Total Liabilities | $1,891,996 (72.76%) | $1,095,157 (-47.08%) | $2,069,643 (-0.99%) | $2,090,398 (31.01%) |
Liabilities Current | $605,230 (-32.98%) | $903,095 (-46.99%) | $1,703,724 (10.36%) | $1,543,767 (56.46%) |
Liabilities Non-Current | $1,286,766 (569.97%) | $192,062 (-47.51%) | $365,919 (-33.06%) | $546,631 (-10.24%) |
NDRA Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $7,626,854 (38.24%) | $5,517,040 (-16.45%) | $6,603,365 (9.77%) | $6,015,774 (7.73%) |
Research & Development Expense | $3,190,293 (-36.24%) | $5,003,695 (-23.66%) | $6,554,194 (19.55%) | $5,482,531 (-7.36%) |
Operating Expenses | $10,817,147 (2.82%) | $10,520,735 (-20.04%) | $13,157,559 (14.85%) | $11,456,760 (-0.47%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$11,507,947 (-14.39%) | -$10,060,250 (23.67%) | -$13,179,092 (-17.34%) | -$11,231,250 (4.22%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$11,507,947 (-14.39%) | -$10,060,250 (23.67%) | -$13,179,092 (-17.34%) | -$11,231,250 (4.22%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $121,071 (-69.39%) |
Net Income Common Stock | -$11,507,947 (-14.39%) | -$10,060,250 (23.67%) | -$13,179,092 (-16.09%) | -$11,352,321 (6.34%) |
Weighted Average Shares | $202,106 (5458.47%) | $3,636 (120.10%) | $1,652 (41.32%) | $1,169 (113.32%) |
Weighted Average Shares Diluted | $202,106 (5458.47%) | $3,636 (120.10%) | $1,652 (41.32%) | $1,169 (113.32%) |
Earning Before Interest & Taxes (EBIT) | -$11,507,947 (-14.39%) | -$10,060,250 (23.67%) | -$13,179,092 (-17.34%) | -$11,231,250 (4.22%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$10,817,147 (-2.82%) | -$10,520,735 (20.04%) | -$13,157,559 (-14.85%) | -$11,456,760 (0.47%) |
NDRA Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$12,796 (48.24%) | -$24,721 (87.80%) | -$202,577 (-350.17%) | -$45,000 (40.27%) |
Net Cash Flow from Financing | $7,808,917 (3.87%) | $7,518,305 (-10.49%) | $8,399,512 (-37.32%) | $13,401,602 (12.86%) |
Net Cash Flow from Operations | -$7,400,547 (22.50%) | -$9,548,775 (25.22%) | -$12,769,371 (-14.81%) | -$11,122,384 (-3.50%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $395,573 (119.25%) | -$2,055,191 (55.05%) | -$4,572,436 (-304.65%) | $2,234,218 (112.15%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$12,796 (48.24%) | -$24,721 (87.80%) | -$202,577 (-350.17%) | -$45,000 (40.27%) |
Issuance (Repayment) of Debt Securities | -$28,484 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $7,837,400 (4.24%) | $7,518,305 (-10.49%) | $8,399,512 (-20.88%) | $10,615,975 (56.56%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $571,924 (-42.60%) | $996,430 (-16.95%) | $1,199,838 (-16.94%) | $1,444,572 (-31.29%) |
Depreciation Amortization & Accretion | $206,172 (-25.15%) | $275,451 (17.58%) | $234,258 (4.39%) | $224,415 (35.80%) |
NDRA Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -210.60% (-16.61%) | -180.60% (-36.40%) | -132.40% (-65.50%) | -80.00% (76.89%) |
Return on Average Assets (ROAA) | -162.50% (-22.18%) | -133.00% (-20.80%) | -110.10% (-55.95%) | -70.60% (68.86%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -384.40% (-12.60%) | -341.40% (17.93%) | -416.00% (15.26%) | -490.90% (59.44%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.11 (91.80%) | -1.34 (-50.17%) | -0.89 (64.18%) | -2.49 (-109.50%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 1.31 (-58.54%) | 3.17 (77.52%) | 1.78 (-34.05%) | 2.71 (3.01%) |
Debt to Equity Ratio (D/E) | 0.74 (280.93%) | 0.19 (-32.40%) | 0.29 (47.94%) | 0.19 (-13.00%) |
Earnings Per Share (EPS) | -56.94 (97.94%) | -2,766.85 (65.33%) | -7,980 (17.84%) | -9,712.5 (55.95%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -36.68 (98.61%) | -2,632.97 (66.47%) | -7,851.48 (17.80%) | -9,551.14 (51.60%) |
Book Value Per Share (BVPS) | 12.67 (-99.19%) | 1,556.38 (-64.31%) | 4,360.64 (-52.72%) | 9,223.45 (-29.45%) |
Tangible Assets Book Value Per Share (TABVPS) | 22.03 (-98.81%) | 1,857.58 (-66.91%) | 5,613.32 (-49.02%) | 11,011.31 (-31.11%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | -1 (0%) | 0 (0%) | -2 (-100.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.02 (101.37%) | -1.53 (-266.35%) | -0.42 (74.50%) | -1.64 (-20.72%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 5.67 (68.94%) | 3.36 (6.37%) | 3.16 (-59.70%) | 7.83 (-5.83%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$7,413,343 (22.56%) | -$9,573,496 (26.20%) | -$12,971,948 (-16.16%) | -$11,167,384 (-3.19%) |
Enterprise Value (EV) | -$236,425 (-101.57%) | $15,024,155 (177.15%) | $5,420,962 (-70.03%) | $18,086,069 (14.94%) |
Earnings Before Tax (EBT) | -$11,507,947 (-14.39%) | -$10,060,250 (23.67%) | -$13,179,092 (-17.34%) | -$11,231,250 (4.22%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$11,301,775 (-15.50%) | -$9,784,799 (24.41%) | -$12,944,834 (-17.61%) | -$11,006,835 (4.79%) |
Invested Capital | $2,001,355 (-41.34%) | $3,411,547 (5.69%) | $3,227,956 (26.67%) | $2,548,304 (106.10%) |
Working Capital | $2,828,435 (32.81%) | $2,129,717 (-42.06%) | $3,675,673 (-65.16%) | $10,550,348 (46.10%) |
Tangible Asset Value | $4,452,362 (-34.08%) | $6,754,146 (-27.17%) | $9,274,147 (-27.97%) | $12,874,644 (46.89%) |
Market Capitalization | $3,361,044 (-81.25%) | $17,924,434 (39.42%) | $12,855,998 (-55.93%) | $29,170,248 (54.93%) |
Average Equity | $5,464,291 (-1.92%) | $5,571,222 (-44.02%) | $9,952,711 (-29.89%) | $14,195,594 (305.50%) |
Average Assets | $7,083,676 (-6.35%) | $7,564,182 (-36.78%) | $11,965,750 (-25.60%) | $16,082,576 (200.78%) |
Invested Capital Average | $2,993,774 (1.59%) | $2,946,898 (-6.98%) | $3,168,190 (38.49%) | $2,287,713 (136.14%) |
Shares | 536,908 (11013.81%) | 4,831 (167.65%) | 1,805 (49.79%) | 1,205 (68.06%) |
